The Anti-Tumor Activity of a Neutralizing Nanobody Targeting Leptin Receptor in a Mouse Model of Melanoma

• Travis McMurphy,

  Affiliations Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Run Xiao,

  Affiliations Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Daniel Magee,

  Affiliations Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Andrew Slater,

  Affiliations Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Lennart Zabeau,

  Affiliation Flanders Institute for Biotechnology, Department of Medical Protein Research, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

  ⨯
• Jan Tavernier,

  Affiliation Flanders Institute for Biotechnology, Department of Medical Protein Research, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

  ⨯
• Lei Cao

  * E-mail: lei.cao@osumc.edu

  Affiliations Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  ⨯